📰 Brigitte Keller News
Brigitte Keller News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brigitte Keller. Real-time updates on events, politics, business and more.
June 1, 2023
EQS-News: Apogenix AG / Key word(s): Scientific publication Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model 01.06.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. Apogenix’ new CD40 agonist...
March 27, 2023
EQS-News: Apogenix AG / Key word(s): Study/Study results Apogenix' Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept
January 25, 2023
EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management – Positive Phase I data of client Memo Therapeutics AG 25.01.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. VPM ov...
January 25, 2023
EQS-News: Vakzine Projekt Management GmbH / Key word(s): Study results VPM oversees clinical trial and translational project management - Positive Phase I data of client Memo Therapeutics
November 23, 2022
EQS-News: HepaRegeniX GmbH / Key word(s): Personnel HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor 23.11.2022 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement. HepaRegeniX appoints Dr. Andreas Busch as Senior Advisor Tübingen (Germany), November 2...
November 23, 2022
The Series B funding was extended by 25 million euros to reach a total of 42 million euros The new funding enables a further expansion of the Temedica...
November 21, 2022
EQS-News: Marinomed Biotech AG / Key word(s): Quarter Results Marinomed Biotech AG reports increase in revenues for the first 9 month...
October 20, 2022
EQS-News: Marinomed Biotech AG / Key word: Conference First successful year on the market for Marinomed’s Solv4U technology partnerships 20.10.2022 / 07:45 CET/CEST The...
October 19, 2022
EQS-News: Apogenix AG / Key word(s): Study resultsApogenix’ Asunercept Demonstrates Efficacy in Phase II Trial for the Treatment of Hospitalized COVID-19 Patients 19.10.2022 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Press ReleaseApogenix’ Asunercept Demonstrates Efficacy i...
September 13, 2022
DGAP-News: Marinomed Biotech AG / Key word(s): Conference Marinomed to attend several upcoming investor and industry conferences ...